These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31378511)

  • 21. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy.
    Hoskin PJ; Rojas AM; Ostler PJ; Hughes R; Lowe GJ; Bryant L
    Clin Oncol (R Coll Radiol); 2013 May; 25(5):321-7. PubMed ID: 23384799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term urinary quality of life after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):454-61. PubMed ID: 12738320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy.
    Kikkawa K; Iba A; Kohjimoto Y; Noda Y; Sonomura T; Hara I
    Int J Urol; 2018 Apr; 25(4):366-371. PubMed ID: 29397569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.
    Yamada Y; Masui K; Iwata T; Naitoh Y; Yamada K; Miki T; Okihara K
    Brachytherapy; 2015; 14(2):118-23. PubMed ID: 25304650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal function following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Galbreath RW; Blatt H; Lief JH
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):667-74. PubMed ID: 11020562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
    Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
    J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT).
    Joseph KJ; Alvi R; Skarsgard D; Tonita J; Pervez N; Small C; Tai P
    Radiat Oncol; 2008 Jul; 3():20. PubMed ID: 18627617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study.
    Parry MG; Nossiter J; Cowling TE; Sujenthiran A; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
    Radiother Oncol; 2021 Feb; 155():48-55. PubMed ID: 33075390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.
    Blanchard P; Pugh TJ; Swanson DA; Mahmood U; Chen HC; Wang X; Graber WJ; Kudchadker RJ; Bruno T; Feeley T; Frank SJ
    Brachytherapy; 2018; 17(2):265-276. PubMed ID: 29269207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
    Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
    Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2009 Aug; 39(8):502-8. PubMed ID: 19477898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.
    Sugimoto M; Takegami M; Suzukamo Y; Fukuhara S; Kakehi Y
    Int J Urol; 2008 Jun; 15(6):524-8. PubMed ID: 18422571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.
    Shahid N; Loblaw A; Chung HT; Cheung P; Szumacher E; Danjoux C; Sankreacha R; Zhang L; Deabreu A; Mamedov A; Morton G
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):412-420. PubMed ID: 28190638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
    Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
    Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Changes in Health-related Quality of Life After
    Ogasawara N; Nakiri M; Kurose H; Ueda K; Chikui K; Nishihara K; Matsuo M; Suekane S; Murotani K; Muraki K; Hattori C; Ogo E; Igawa T; Ishitake T
    Anticancer Res; 2020 Nov; 40(11):6443-6456. PubMed ID: 33109583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.